Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Haddock

Showing results (251-260 of 268) with videos related to

Pageof 27
Sort By:
Practical Radiation Oncology|July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Advances in Radiation Oncology|October 14, 2021
Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the AnusJahan J Mohiuddin, Krishan R Jethwa, Nikhil Grandhi, et al.
Practical Radiation Oncology|November 29, 2025
Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice GuidelineChristopher J Anker, Junaid Arshad, Francesco Cellini, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal AdenocarcinomaWilliam A Hall, Jiahe Li, Y Nancy You, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Practical Radiation Oncology|January 31, 2016
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice reviewCharles S Mayo, Thomas M Pisansky, Ivy A Petersen, et al.
Cancer|March 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomaLisa A Kachnic, Jennifer Moughan, Theodore S Hong, et al.
The Lancet. Oncology|January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trialHoward P Safran, Kathryn Winter, David H Ilson, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Pageof 27

Showing results (251-260 of 268) with videos related to

Sort By:
Pageof 27
Practical Radiation Oncology|July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Advances in Radiation Oncology|October 14, 2021
Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the AnusJahan J Mohiuddin, Krishan R Jethwa, Nikhil Grandhi, et al.
Practical Radiation Oncology|November 29, 2025
Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice GuidelineChristopher J Anker, Junaid Arshad, Francesco Cellini, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 27, 2024
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgeryLisa A Kachnic, Kathryn Winter, Mohan Suntharalingam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal AdenocarcinomaWilliam A Hall, Jiahe Li, Y Nancy You, et al.
Frontiers in Oncology|May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Practical Radiation Oncology|January 31, 2016
Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice reviewCharles S Mayo, Thomas M Pisansky, Ivy A Petersen, et al.
Cancer|March 11, 2026
Patient-reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinomaLisa A Kachnic, Jennifer Moughan, Theodore S Hong, et al.
The Lancet. Oncology|January 17, 2022
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trialHoward P Safran, Kathryn Winter, David H Ilson, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Pageof 27